| Sargine Brutus, | |
|
2815 S Seacrest Blvd, Boynton Beach, FL 33435-7969 | |
| (917) 324-1781 | |
| Not Available |
| Full Name | Sargine Brutus |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 2815 S Seacrest Blvd, Boynton Beach, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417999285 | NPI | - | NPPES |
| 451601000 | Medicaid | MD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rome Memorial Hospital, Inc | Rome, NY | Hospital |
| Lourdes Hospital | Binghamton, NY | Hospital |
| Lawnwood Regional Medical Center & Heart Institute | Fort pierce, FL | Hospital |
| Fawcett Memorial Hospital | Port charlotte, FL | Hospital |
| Northside Hospital | Saint petersburg, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Park Hill Emergency Physician Services | 5395057020 | 13 |
| Exigence Medical Of Binghamton Pllc | 7012913916 | 14 |
| Emergency Physician Services Of New York, P.c. | 8325939804 | 92 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | Dobbs Ferry Emergency Medicine, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457381477 PECOS PAC ID: 8022908268 Enrollment ID: O20040319000362 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | White Plains Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003089491 PECOS PAC ID: 4981593092 Enrollment ID: O20040420001230 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | Emergency Physician Services Of New York, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093759847 PECOS PAC ID: 8325939804 Enrollment ID: O20040901000528 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | Emergency Physician Services Of New York, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093759847 PECOS PAC ID: 8325939804 Enrollment ID: O20041001000684 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | Exigence Medical Of Binghamton Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659464758 PECOS PAC ID: 7012913916 Enrollment ID: O20061017000476 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | Interfaith Emergency Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457643785 PECOS PAC ID: 7012186638 Enrollment ID: O20110816000191 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | Medical Services Of Suffolk County Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811235724 PECOS PAC ID: 8527209246 Enrollment ID: O20130723000586 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | Park Hill Emergency Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396123360 PECOS PAC ID: 5395057020 Enrollment ID: O20150708002564 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | East Post Road Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841767274 PECOS PAC ID: 6406198506 Enrollment ID: O20190419000178 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Entity Name | Delaware River Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457987521 PECOS PAC ID: 4981034550 Enrollment ID: O20200422001405 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sargine Brutus, 11843 235th St, Cambria Heights, NY 11411-2319 Ph: (917) 324-1781 | Sargine Brutus, 2815 S Seacrest Blvd, Boynton Beach, FL 33435-7969 Ph: (917) 324-1781 |
News Archive
HCC Medical Insurance Services, LLC has been selected as a nominee for the 2010 Techpoint MIRA Awards. Now in its 11th year, the MIRA Awards acknowledge advancements made by businesses, schools and individuals in technology-related industries.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.
› Verified 3 days ago
Suzanne Elizabeth Newstead, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2815 S Seacrest Blvd, Boynton Beach, FL 33435 Phone: 718-830-4639 Fax: 718-275-7806 | |
Dr. Simran Hamid, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2815 S Seacrest Blvd, Boynton Beach, FL 33435 Phone: 561-737-7733 | |
Christopher Schirmer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2815 S Seacrest Blvd, Boynton Beach, FL 33435 Phone: 561-737-7733 | |
Dr. Daniella Lamour, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2815 S Seacrest Blvd, Boynton Beach, FL 33435 Phone: 561-737-7733 | |
Sharif Salehi, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2815 S Seacrest Blvd, Boynton Beach, FL 33435 Phone: 561-737-7733 | |
Dr. Thomas Rex Peterson, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Fau Emergency Medicine, Bethesda Hospital East, Attn: Joanne Daly, 2815 S. Seacrest Blvd., Boynton Beach, FL 33435 Phone: 561-733-5933 Fax: 866-617-8268 | |
Zachariah Hatoum, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2815 South Seacrest Blvd., Gme Suite Lower Level B, Boynton Beach, FL 33435 Phone: 561-737-7733 |